---
figid: PMC10502727__fimmu-14-1257254-g001
figtitle: Basic research on chordoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10502727
filename: PMC10502727__fimmu-14-1257254-g001.jpg
figlink: /pmc/articles/PMC10502727/figure/F1
number: F1
caption: The basic research on chordoma. Chordoma studies mainly focus on the signaling
  pathway, brachyury, and non-coding RNAs. Various receptors and signaling pathways
  are dysregulated in chordoma; using imatinib, dastinib, and erotinib can inhibit
  the corresponding signaling pathways for targeted therapy. Brachyury plays a driving
  role in chordoma, causing a variety of malignant genes upregulated by binding to
  super enhancers. Non-coding RNAs are also dysregulated and lead to tumor progression.
papertitle: 'The role of tumor immune microenvironment in chordoma: promising immunotherapy
  strategies'
reftext: Jiuhui Xu, et al. Front Immunol. 2023;14(16):1257254.
year: '2023'
doi: 10.3389/fimmu.2023.1257254
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: chordoma | tumor immune environment | immune-excluded | immune checkpoint
  inhibitor (ICI) | immunotherapy
automl_pathway: 0.9654187
figid_alias: PMC10502727__F1
figtype: Figure
redirect_from: /figures/PMC10502727__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10502727__fimmu-14-1257254-g001.html
  '@type': Dataset
  description: The basic research on chordoma. Chordoma studies mainly focus on the
    signaling pathway, brachyury, and non-coding RNAs. Various receptors and signaling
    pathways are dysregulated in chordoma; using imatinib, dastinib, and erotinib
    can inhibit the corresponding signaling pathways for targeted therapy. Brachyury
    plays a driving role in chordoma, causing a variety of malignant genes upregulated
    by binding to super enhancers. Non-coding RNAs are also dysregulated and lead
    to tumor progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - MET
  - KDR
  - FLT1
  - FLT4
  - PDGFRB
  - PDGFRA
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - IGF1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SMAD3
  - MTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ITK
  - SLC22A3
  - imatinib
  - MEK
---
